As pot stocks boom on hopes for U.S. legalization, Canadian cannabis companies struggle for growth

Cannabis Watch: Canopy revenue grows, but Tilray’s sales are stagnant and Aurora sales decline while a prominent partnership costs $40 million to end

Cannabis stocks rally for a second straight day with Aurora gaining 66% as Biden’s gains raise reform hopes

‘While Tuesday night’s election did not clearly show who America thinks should lead the nation, it did make clear that we are united on replacing our country’s archaic cannabis laws,’ says CCPC

Aurora Cannabis soars 34% to lead weed stock rally fueled by Biden’s lead in presidential race

‘I would say this was one of the best case scenarios for cannabis investors,’ says Korey Bauer, portfolio manager of the Cannabis Growth Fund

Canadian cannabis company agrees to buy U.S. craft-beer maker Sweetwater, known for its ‘420’-branded brews

GW Pharma shares rally on earnings and news of late-stage trial of cannabis-based treatment for MS patients

Aurora Cannabis stock slides nearly 12% on news of up to $1.4 billion goodwill impairment charge

Aurora names CCO Miguel Martin as new CEO

FDA releases guidelines for cannabis-related research, but CBD will have to wait

FDA outlines road to approval involves clinical trials

Attorney General Barr ordered antitrust probes of 10 cannabis mergers, because he dislikes the industry, prosecutor says

‘While these were nominally antitrust investigations, and used antitrust investigative ities, they were not bona fide antitrust investigations,’ says John Elias

Cannabis producer Canopy Growth reports another billion-dollar loss

Canopy’s huge loss resulted from shuttered facilities and obsolete packaging, marijuana

Inside the Aurora Cannabis move into the U.S. CBD market

Reliva had been trying to raise venture-capital money at a $40 million valuation before taking that amount in Aurora stock for acquisition

Aurora Cannabis makes its long-awaited push into the U.S. with Reliva CBD acquisition

Aurora shares surge nearly 30% in the extended session

Aurora Cannabis on CEO search during a pandemic: drone tours, no handshakes

Interim chief executive Michael Singer says Aurora is using video meetings and drone tours of facilities, and is willing to hire a new leader without an in-person meeting

Aurora Cannabis shares skyrocket on hopes worst is behind Canadian weed company

‘We think ACB can become a solid cash-flow generator simply from the Canadian operations,’ Ladenburg Thalmann analyst says

Aurora Cannabis stock enjoys best and busiest day ever after pot sales grow

Shares rise nearly 70% on volume more than 30 times greater than average after pot company reports stronger-than-expected revenue growth

‘It’s been one fight after another’: Some cannabis companies must close, while liquor stores are allowed to open

Having access to the CARE Act’s Paycheck Protection Program would have been a lifeline for these companies, owners say

Tilray says coronavirus has not dented operations

International medical cannabis sales exceed those in Canada, CEO says cannabis revenue has picked up amid global pandemic

Aurora Cannabis rolls up its shares in a reverse stock split — here’s what you need to know

Canadian pot company was facing delisting by New York Stock Exchange as shares traded for less than $1

Aurora Cannabis and Tilray set to detail hoarding of marijuana during COVID-19

Data suggests that consumers stocked up on pot at end of March, but the surge likely didn’t continue into April

Pot companies left out of latest coronavirus stimulus bill, but lobbyists are still hopeful

‘This is the first time I’ve seen the federal trade associations for cannabis rolling in the same direction,’ insider says of lobbying efforts

Which cannabis companies are going to survive coronavirus? Here’s how to tell

The sector was already shaky before COVID-19, but companies must now have the right mix of cash, pot and sales channels to make it to the other side